Activist Investor Sees Alere Inc. Shares Soaring if Asset Sales Plan Adopted

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Philips announces FDA clearance for its AlluraClarity interventional X-ray system

Coppersmith Capital Management LLC made the claim in a letter to fellow Alere investors. Coppersmith Capital Management LLC has a roughly 7% ownership in Alere. Four of the ten board of directors are due to be replaced at its annual shareholder meeting in August. Coppersmith wants Alere shareholders to support its three candidates as opposed to a Waltham, a Massachusetss-based company, group of nominees to the board. Coppersmith, in their strategy detailed in the letter, called for Alere to sell its non-core businesses which includes its health care management business, called Health Information Solutions, its joint venture project with Procter & Gamble, and a toxicology unit.

Help employers find you! Check out all the jobs and post your resume.

Back to news